Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (2017)
Fonte: The New England Journal of Medicine. Unidade: FM
Assuntos: COLESTEROL, PLACEBO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M. et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, v. 376, n. 16, p. 1527-1539, 2017Tradução . . Disponível em: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488. Acesso em: 01 nov. 2024.APA
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376( 16), 1527-1539. doi:10.1056/NEJMoa1701488NLM
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.[citado 2024 nov. 01 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488Vancouver
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.[citado 2024 nov. 01 ] Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
